{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:44:48Z","timestamp":1792100688728,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016622","name":"Osteosarcoma Institute","doi-asserted-by":"publisher","award":["1048675"],"award-info":[{"award-number":["1048675"]}],"id":[{"id":"10.13039\/100016622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"Saint Baldricks Foundation","doi-asserted-by":"publisher","award":["968281"],"award-info":[{"award-number":["968281"]}],"id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","award":["RT-2023-3194"],"award-info":[{"award-number":["RT-2023-3194"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA220500"],"award-info":[{"award-number":["R35CA220500"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["1U54CA232568-01"],"award-info":[{"award-number":["1U54CA232568-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017012","name":"Children's Oncology Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020487","name":"Break Through Cancer","doi-asserted-by":"publisher","award":["1190-10"],"award-info":[{"award-number":["1190-10"]}],"id":[{"id":"10.13039\/100020487","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.celrep.2026.117884","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:37:06Z","timestamp":1787737026000},"page":"117884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2834-9781","authenticated-orcid":false,"given":"Brian","family":"Mooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Lizardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harley","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Delaidelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue Z.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Shraim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Magesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Budhathoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew V.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gorlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Sweet-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Diskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Maris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg B.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-2199","authenticated-orcid":false,"given":"Poul H.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117884_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.celrep.2026.117884_bib2","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra2103423","article-title":"New Horizons in the Treatment of Osteosarcoma","volume":"385","author":"Meltzer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117884_bib4","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1101\/gad.1656808","article-title":"Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease","volume":"22","author":"Walkley","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2026.117884_bib5","first-page":"900","article-title":"Survival nomogram for osteosarcoma patients: SEER data retrospective analysis with external validation","volume":"13","author":"Liu","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117884_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117884_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.2019000324","article-title":"Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087","volume":"134","author":"Chen","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2026.117884_bib9","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair\u2013Deficient Colon Cancer","volume":"390","author":"Chalabi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/2326-6066.CIR-19-0692","article-title":"Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies","volume":"8","author":"Casey","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celrep.2026.117884_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(17)30624-1","article-title":"Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2026.117884_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib14","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/1078-0432.CCR-23-2187","article-title":"Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma","volume":"30","author":"Mooney","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117884_bib15","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/ijms24032601","article-title":"Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma","volume":"24","author":"Timpanaro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2026.117884_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114260","article-title":"Immunotherapeutic targeting of surfaceome heterogeneity in AML","volume":"43","author":"Bordeleau","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117884_bib17","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1038\/s41467-022-31810-6","article-title":"The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance","volume":"13","author":"Ferguson","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117884_bib18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1158\/1535-7163.MCT-21-0836","article-title":"Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2026.117884_bib19","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1200\/JCO.23.02229","article-title":"STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed\/Refractory Solid Tumors","volume":"42","author":"Pinto","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117884_bib20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor Antigen Escape from CAR T-cell Therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117884_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1070492","article-title":"Human antibodies targeting ENPP1 as candidate therapeutics for cancers","volume":"14","author":"Chu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117884_bib22","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.celrep.2019.09.071","article-title":"Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design","volume":"29","author":"Rokita","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117884_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1158\/1078-0432.CCR-23-0873","article-title":"Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach","volume":"30","author":"Schott","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117884_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201600344","article-title":"Improved surfaceome coverage with a label-free nonaffinity-purified workflow","volume":"17","author":"Glisovic-Aplenc","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.celrep.2026.117884_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2025.104049","article-title":"Protocol for plasma membrane enrichment by ultracentrifugation for mass spectrometry of cell lines, xenografts, and patient tumors","volume":"6","author":"Hamilton","year":"2025","journal-title":"STAR Protoc."},{"key":"10.1016\/j.celrep.2026.117884_bib26","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1093\/bioinformatics\/btaa092","article-title":"SurfaceGenie: a web-based application for prioritizing cell-type-specific marker candidates","volume":"36","author":"Waas","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117884_bib27","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1021\/pr500893m","article-title":"Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics","volume":"13","author":"Batth","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.celrep.2026.117884_bib28","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1038\/s41467-022-34689-5","article-title":"Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117884_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/2159-8290.CD-25-0237","article-title":"Epigenetic and transcriptional programs define osteosarcoma subtypes and establish targetable vulnerabilities","volume":"16","author":"L\u00f3pez-Fuentes","year":"2026","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117884_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28771","article-title":"LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studies","volume":"68","author":"Slemmons","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.celrep.2026.117884_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fonc.2018.00470","article-title":"Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6\/\u03b2-Catenin\/IGFR-IR Signaling Axis","volume":"8","author":"Aggelidakis","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2026.117884_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lfs.2012.10.021","article-title":"Cell adhesion molecule 1 is a new osteoblastic cell adhesion molecule and a diagnostic marker for osteosarcoma","volume":"92","author":"Inoue","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.celrep.2026.117884_bib33","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1158\/1078-0432.CCR-06-1343","article-title":"The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate","volume":"13","author":"Yang","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117884_bib34","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1158\/1535-7163.MCT-22-0312","article-title":"Endo180 ( MRC2 ) Antibody\u2013Drug Conjugate for the Treatment of Sarcoma","volume":"22","author":"Evans","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2026.117884_bib35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/1535-7163.MCT-25-0450","article-title":"Identification of CADM1 as an Immunotherapeutic Target and Evaluation of a Novel CADM1-Targeting Antibody-Drug Conjugate in Preclinical Osteosarcoma Models","volume":"25","author":"Wang","year":"2026","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2026.117884_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154443","article-title":"Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling","volume":"245","author":"Mori","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.celrep.2026.117884_bib37","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1038\/s41467-023-39097-x","article-title":"ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma","volume":"14","author":"Mensali","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117884_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12935-017-0482-y","article-title":"ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a","volume":"17","author":"Dai","year":"2017","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.celrep.2026.117884_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.41","article-title":"Upregulation and biological function of transmembrane protein 119 in osteosarcoma","volume":"49","author":"Jiang","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib40","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/bioinformatics\/btt607","article-title":"Protter: interactive protein feature visualization and integration with experimental proteomic data","volume":"30","author":"Omasits","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117884_bib41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2026.117884_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209563119","article-title":"Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody","volume":"119","author":"Micalizzi","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117884_bib43","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1158\/2767-9764.CRC-25-0086","article-title":"Preclinical Evaluation of Folate Receptor-\u03b1 Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma","volume":"5","author":"Choe","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.celrep.2026.117884_bib44","doi-asserted-by":"crossref","first-page":"TPS6107","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS6107","article-title":"A phase 2 open-label study of conditionally active biologic ozuriftamab vedotin (BA3021) in failed PD-1\/L1 treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"41","author":"Ho","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117884_bib45","article-title":"Integrative Single-cell and Spatial Transcriptomic Analysis of Osteosarcoma Reveals Conserved and Distinct Ecosystems Across Sites and Species","author":"Budhathoki","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2026.117884_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1975.136","article-title":"The metastatic patterns of osteosarcoma","volume":"32","author":"Jeffree","year":"1975","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.celrep.2026.117884_bib47","article-title":"Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay","volume":"56332","author":"Lizardo","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.celrep.2026.117884_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2008.01.029","article-title":"Blocking neuropilin-2 function inhibits tumor cell metastasis","volume":"13","author":"Caunt","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2026.117884_bib49","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1158\/0008-5472.CAN-13-0529","article-title":"Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial \u03b15 integrin","volume":"73","author":"Cao","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117884_bib50","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1158\/2159-8290.CD-20-1690","article-title":"Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.117884_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2021.09.019","article-title":"WNT5B in cellular signaling pathways","volume":"125","author":"Perkins","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.celrep.2026.117884_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2405217121","article-title":"Wnt7b acts in concert with Wnt5a to regulate tissue elongation and planar cell polarity via noncanonical Wnt signaling","volume":"121","author":"Xie","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2026.117884_bib53","doi-asserted-by":"crossref","first-page":"26301","DOI":"10.1074\/jbc.M113.466086","article-title":"Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer","volume":"288","author":"Rasmussen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117884_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2490078","article-title":"Preclinical development of ozuriftamab vedotin (BA3021), a novel ROR2-specific conditionally active biologic antibody-drug conjugate","volume":"17","author":"Chang","year":"2025","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2026.117884_bib55","doi-asserted-by":"crossref","first-page":"D923","DOI":"10.1093\/nar\/gky872","article-title":"Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models","volume":"47","author":"van der Meer","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117884_bib56","article-title":"Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research","volume":"7","author":"Yang","year":"2023","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.celrep.2026.117884_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000915","article-title":"Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets","volume":"8","author":"Oldham","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2026.117884_bib58","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/1078-0432.CCR-24-2335","article-title":"LRRC15-CAR T Cells for the Treatment of Osteosarcoma","volume":"32","author":"O\u2019Reilly","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117884_bib59","article-title":"Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma","volume":"4","author":"Lee","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib60","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.2147\/CMAR.S260149","article-title":"MicroRNA-431-5p Inhibits the Tumorigenesis of Osteosarcoma Through Targeting PANX3","volume":"12","author":"Sun","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.celrep.2026.117884_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1481558","article-title":"Systematic identification of cancer-specific MHC-binding peptides with RAVEN","volume":"7","author":"Baldauf","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.celrep.2026.117884_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/282745","article-title":"The Role of RUNX2 in Osteosarcoma Oncogenesis","volume":"2011","author":"Martin","year":"2011","journal-title":"Sarcoma"},{"key":"10.1016\/j.celrep.2026.117884_bib63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2407-6-237","article-title":"Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma","volume":"6","author":"Dalla-Torre","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.celrep.2026.117884_bib64","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/modpathol.2012.110","article-title":"Regulators of skeletal development: a cluster analysis of 206 bone tumors reveals diagnostically useful markers","volume":"25","author":"Horvai","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.celrep.2026.117884_bib65","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1349-7006.2009.01165.x","article-title":"Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma","volume":"100","author":"Morioka","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.celrep.2026.117884_bib66","article-title":"ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice","volume":"6","author":"Weber","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111589","article-title":"Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma","volume":"28","author":"Leng","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2026.117884_bib68","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1200\/JCO.2025.43.16_suppl.6048","article-title":"Phase 2 trial of ozuriftamab vedotin (BA3021), a conditionally binding ROR2-ADC, in patients with heavily pretreated squamous cell carcinoma of the head and neck","volume":"43","author":"Adkins","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117884_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/neup.12235","article-title":"TMEM119 marks a subset of microglia in the human brain","volume":"36","author":"Satoh","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.celrep.2026.117884_bib70","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/cam4.4975","article-title":"Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.celrep.2026.117884_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btaf060","article-title":"ImmunoTar-integrative prioritization of cell surface targets for cancer immunotherapy","volume":"41","author":"Shraim","year":"2025","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2026.117884_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","article-title":"Drug repurposing for cancer therapy","volume":"9","author":"Xia","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.117884_bib73","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/1535-7163.MCT-14-1095","article-title":"IMGN853, a Folate Receptor-\u03b1 (FR\u03b1)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FR\u03b1-Expressing Tumors","volume":"14","author":"Ab","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2026.117884_bib74","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1056\/NEJMoa2309169","article-title":"Mirvetuximab Soravtansine in FR\u03b1-Positive, Platinum-Resistant Ovarian Cancer","volume":"389","author":"Moore","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117884_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184305","article-title":"CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target","volume":"134","author":"Le","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117884_bib76","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3390\/cells12172179","article-title":"Comparative Shotgun Proteomics Reveals the Characteristic Protein Signature of Osteosarcoma Subtypes","volume":"12","author":"Alaa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2026.117884_bib77","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/pbc.21078","article-title":"The pediatric preclinical testing program: description of models and early testing results","volume":"49","author":"Houghton","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.celrep.2026.117884_bib78","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood-2014-11-612903","article-title":"Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein","volume":"126","author":"Qin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2026.117884_bib79","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1158\/1078-0432.CCR-24-1317","article-title":"Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma Metastasis","volume":"30","author":"Lizardo","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117884_bib80","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI40252","article-title":"Modeling metastasis biology and therapy in real time in the mouse lung","volume":"120","author":"Mendoza","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117884_bib81","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117884_bib82","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","article-title":"Single-pot, solid-phase-enhanced sample preparation for proteomics experiments","volume":"14","author":"Hughes","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2026.117884_bib83","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/ac026117i","article-title":"Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics","volume":"75","author":"Rappsilber","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.celrep.2026.117884_bib84","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1074\/mcp.TIR119.001646","article-title":"DEqMS: A Method for Accurate Variance Estimation in Differential Protein Expression Analysis","volume":"19","author":"Zhu","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.celrep.2026.117884_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-Response Analysis Using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726009629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726009629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:58:00Z","timestamp":1792097880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726009629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211124726009629"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117884","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117884"}}